174 related articles for article (PubMed ID: 3141347)
1. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.
Hill RL; Duckworth GJ; Casewell MW
J Antimicrob Chemother; 1988 Sep; 22(3):377-84. PubMed ID: 3141347
[TBL] [Abstract][Full Text] [Related]
2. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
3. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
4. Nasal carriage of MRSA: the role of mupirocin and outlook for resistance.
Hill RL; Casewell MW
Drugs Exp Clin Res; 1990; 16(8):397-402. PubMed ID: 2129029
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
Safdar N; Marx J; Meyer NA; Maki DG
Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
[TBL] [Abstract][Full Text] [Related]
6. The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopaedic unit.
Barrett SP
J Hosp Infect; 1990 Feb; 15(2):137-42. PubMed ID: 1969435
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.
Dupeyron C; Campillo B; Bordes M; Faubert E; Richardet JP; Mangeney N
J Hosp Infect; 2002 Dec; 52(4):281-7. PubMed ID: 12473473
[TBL] [Abstract][Full Text] [Related]
9. Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA.
Casewell MW; Hill RL
J Hosp Infect; 1991 Sep; 19 Suppl B():35-40. PubMed ID: 1684191
[TBL] [Abstract][Full Text] [Related]
10. A major outbreak of methicillin resistant Staphylococcus aureus among patients and staff at Johannesburg Hospital during 1986-1987.
Park C; Pearce J
Nurs RSA; 1989; 4(6):37-9. PubMed ID: 2507921
[No Abstract] [Full Text] [Related]
11. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
12. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?
Walker ES; Vasquez JE; Dula R; Bullock H; Sarubbi FA
Infect Control Hosp Epidemiol; 2003 May; 24(5):342-6. PubMed ID: 12785407
[TBL] [Abstract][Full Text] [Related]
13. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment.
Kauffman CA; Terpenning MS; He X; Zarins LT; Ramsey MA; Jorgensen KA; Sottile WS; Bradley SF
Am J Med; 1993 Apr; 94(4):371-8. PubMed ID: 8475930
[TBL] [Abstract][Full Text] [Related]
14. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization.
Mehta MS; Hacek DM; Kufner BA; Price C; Peterson LR
Surg Infect (Larchmt); 2013 Feb; 14(1):69-72. PubMed ID: 23448592
[TBL] [Abstract][Full Text] [Related]
15. An outbreak of infection with a methicillin-resistant Staphylococcus aureus in a special care baby unit: value of topical mupirocin and of traditional methods of infection control.
Davies EA; Emmerson AM; Hogg GM; Patterson MF; Shields MD
J Hosp Infect; 1987 Sep; 10(2):120-8. PubMed ID: 2889764
[TBL] [Abstract][Full Text] [Related]
16. Survey of high- and low-level mupirocin-resistant strains of methicillin-resistant Staphylococcus aureus in 15 Japanese hospitals.
Fujimura S; Watanabe A
Chemotherapy; 2003 May; 49(1-2):36-8. PubMed ID: 12714808
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.
Parras F; Guerrero MC; Bouza E; Blázquez MJ; Moreno S; Menarguez MC; Cercenado E
Antimicrob Agents Chemother; 1995 Jan; 39(1):175-9. PubMed ID: 7695302
[TBL] [Abstract][Full Text] [Related]
18. Community-genotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit.
Park SH; Kim SY; Lee JH; Park C; Lee DG
Early Hum Dev; 2013 Sep; 89(9):661-5. PubMed ID: 23707691
[TBL] [Abstract][Full Text] [Related]
19. Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin.
Irish D; Eltringham I; Teall A; Pickett H; Farelly H; Reith S; Woodford N; Cookson B
J Hosp Infect; 1998 May; 39(1):19-26. PubMed ID: 9617681
[TBL] [Abstract][Full Text] [Related]
20. Immediate control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit.
Shiojima T; Ohki Y; Nako Y; Morikawa A; Okubo T; Iyobe S
J Infect Chemother; 2003 Sep; 9(3):243-7. PubMed ID: 14513393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
